Cost Pressure and Need for Greater Productivity Fuel Market Growth

The global pharmaceutical industry is witnessing rapid advances in processes and technology, and automation is emerging an integral part of most manufacturing processes. With stricter regulatory norms and spiraling costs, pharmaceutical companies are opting to outsource their manufacturing process to contract manufacturing organizations (CMOs) in order to improve efficiency and productivity. In catering to this growing demand, CMOs are offering strategic value-added services such as process development, marketing support, process optimization, and life cycle management, thereby integrating themselves in the supply chain of the pharmaceutical companies.

This Frost & Sullivan research service examines the global pharmaceutical contract manufacturing markets. It discusses the prevailing market drivers and challenges and presents strategic recommendations to ensure success in these highly competitive markets. The study further examines key trends across global regions and sub-segments, such as injectables, as well as solid and liquid dosage forms, to help identify growth opportunities.